Abstract

IQVIA will report second-quarter 2026 results on July 28, 2026 Pre-MKt; consensus points to mid‑single‑digit to high‑single‑digit revenue growth and continuing margin expansion supported by resilient demand across core segments.

Market Forecast

Market expectations for IQVIA’s current quarter center on revenue of 4.30 billion US dollars, EBIT of 0.81 billion US dollars, and adjusted EPS of 3.03, reflecting year-over-year increases of 8.58%, 9.28%, and 9.41%, respectively; revenue growth is projected to be accompanied by stable-to-improving profitability, with the prior quarter’s gross profit margin as a reference point at 32.64% and net profit margin at 6.60%. Management’s prior commentary and the forecast imply steady performance across IQVIA’s diversified portfolio, with an emphasis on continued momentum in data‑driven solutions and resilient contract research activity.

IQVIA’s main businesses by geography last quarter included the Americas at 1.98 billion US dollars, Europe and Africa at 1.36 billion US dollars, and Asia‑Pacific at 0.81 billion US dollars, indicating broad-based demand; current-quarter growth is expected to be led by Americas and globally scaled technology solutions. The most promising segment is Americas, which generated 1.98 billion US dollars last quarter, with year‑over‑year growth implied by the company’s consolidated 8.41% revenue increase.

Last Quarter Review

IQVIA’s previous quarter delivered revenue of 4.15 billion US dollars, a gross profit margin of 32.64%, GAAP net profit attributable to shareholders of 274.00 million US dollars with a net profit margin of 6.60%, and adjusted EPS of 2.90, with year‑over‑year growth of 8.41% for revenue and 7.41% for adjusted EPS. A key highlight was EBIT rising to 0.78 billion US dollars, marking 4.98% year‑over‑year growth and a modest beat versus consensus, while the company sustained margin discipline alongside top‑line expansion.

Main business highlights show a diversified geographic mix: Americas contributed 1.98 billion US dollars, Europe and Africa 1.36 billion US dollars, and Asia‑Pacific 0.81 billion US dollars, underpinning steady demand across end markets and helping balance currency and macro variations.

Current Quarter Outlook

Main business: Global biopharma solutions and geographic portfolio

IQVIA’s core operations are expected to extend their growth trajectory into the current quarter, with revenue projected at 4.30 billion US dollars and EBIT at 0.81 billion US dollars. The Americas, at just under half of last quarter’s mix, remains the anchor for revenue, and is poised to benefit from consistent project starts and sustained client spend across late‑stage and real‑world evidence work. Europe and Asia‑Pacific provide diversification and visibility, with demand tied to cross‑border trials and ongoing adoption of data‑enabled services. With the prior quarter’s gross margin at 32.64%, the guidance and consensus suggest incremental operating leverage if volume conversion and utilization hold, while currency is a manageable swing factor.

Most promising business: Americas and data‑driven technology solutions

The Americas region combined with globally deployable analytics and technology platforms is positioned to contribute a disproportionate share of incremental growth this quarter. The forecasted adjusted EPS of 3.03 implies continued efficiency gains from scaled data assets and workflow tools that support both clinical and commercial decision‑making. Revenue of 4.30 billion US dollars and EBIT of 0.81 billion US dollars, implying year‑over‑year growth of 8.58% and 9.28%, point to favorable mix benefits as higher‑value solutions gain traction. Execution risk lies in project timing and client budget phasing; however, the breadth of the regional book, along with multi‑year partnerships, provides cushioning against discrete delays.

Key stock price drivers this quarter: Bookings, margins, and cash conversion

Investors will focus on bookings quality and visibility, especially the balance between late‑stage clinical and real‑world evidence pipelines, as indicators for second‑half revenue conversion. Margin commentary will be scrutinized for signs of operating leverage from scale and utilization versus any headwinds from wage inflation or project mix; the prior quarter’s net margin of 6.60% sets a baseline. Cash generation and working capital discipline remain central to equity narratives in information‑enabled services; smoother collections and lower build in unbilled receivables would support confidence in full‑year EPS cadence. Any updates on the pace of digitization within client programs and the adoption curve of analytics platforms could influence multiple expansion.

Analyst Opinions

Analyst sentiment skews bullish, with the majority expecting IQVIA to meet or modestly exceed forecasts on revenue and adjusted EPS given the 8.58% revenue and 9.41% EPS growth projections. Several prominent institutions highlight sustained demand across the Americas and improving visibility in technology‑enabled solutions as drivers of margin resilience. The consensus constructive stance emphasizes that a balanced geographic portfolio and expanding data‑driven offerings provide defense against timing variability in project starts, while execution on bookings and utilization is expected to support steady full‑year progress.